EPI Health, LLC 2024-05-01 Health serious FDA
Health · FDA · Recall #FDA-D-0475-2024
minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx… Recall
Issued May 1, 2024 · EPI Health, LLC
In May 2024, EPI Health, LLC recalled the minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
What you should do
- 1 Stop using minolira (minocycline hydrochloride) extended-release tablets, 135mg 30-count Bottle, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact EPI Health, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- EPI Health, LLC
- Category
- Health
- Recall date
- May 1, 2024
- Units affected
- Not reported
- Sold at
- US Nationwide
- Recall number
- FDA-D-0475-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- EPI Health, LLC has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.